Nabta Health draws PVP into $3M pre-Series A, pivots to employer healthcare
What's the deal? Nabta HealthDealroom has a profile for this one. Try Dealroom →, a UAE women's healthcare company, has secured backing from Phoenix Venture Partners (PVP)Dealroom has a profile for this one. Try Dealroom → as it expands sales to employers, insurers, and healthcare providers. The Abu Dhabi firm led the second close of Nabta's ongoing $3 million pre-Series A, combining new equity with purchases of existing shares. The amount raised at this close and PVP's contribution weren't disclosed.
What's the endgame? Founded in 2017 by Sophie Smith, Nabta combines digital consultations, at-home diagnostics, and clinical services to support women through fertility, pregnancy, menopause, and other needs. Its new workplace offering includes insurance-covered annual checks, preventive care subscriptions, and treatment navigation, supported by its AI assistant Aya.
The aim is to catch health risks earlier and help employers and insurers manage long-term costs. Nabta has also partnered with wellbeing platform LVLDealroom has a profile for this one. Try Dealroom → to pair clinical services with digital support.
Why now? The expansion was already under way when Nabta announced $2 million in pre-Series A funding in November 2025, with plans to broaden diagnostics and develop hospital partnerships. The latest financing is described as an ongoing $3 million round, without a total committed figure.
Nabta has built a physical network too, including a Women's Health Centre of Excellence with Clemenceau Medical Center Hospital Dubai, launched in June 2025.
What's changing? PVP's investment formalises an existing link. Co-founder Mussaad Al-Razouki, a founding Nabta investor and former executive chairman, will leave its board. PVP founder and chief executive Steve Khayat joins as the firm's representative.
Khayat said the priority is turning Nabta's technology and clinical infrastructure into faster sales. "Our role at PVP will be to work alongside Sophie and the team to deepen strategic partnerships, accelerate customer acquisition and help translate that traction into scalable growth," he said.
What could go wrong? The round includes secondary investment, so not all capital flows into the company. And its success rests less on size — a modest $3 million sits in the lower range of comparable raises — than on whether Nabta can convert employer interest into repeatable contracts.
The deal follows PVP completing fundraising for its debut fund this month, reporting about $23 million raised across its Innovation Fund and co-investment vehicles, with 45% still available to deploy.
The signal: Nabta's pivot fits a regional shift toward embedding women's preventive care in workplace benefits, with peers such as UAE-based OvaSaveDealroom has a profile for this one. Try Dealroom → building corporate fertility offerings. The question now is whether demonstrated value to employers and insurers can translate interest into recurring revenue.
Read more: fwdstart.me
Image credit: Generated with Gemini
